Business context and reporting period
This is Information Analysis Incorporated’s unaudited Form 10-Q for the quarter ended March 31, 2015. The filing describes an IT services and software company focused on legacy-system modernization and government web solutions. The request metadata names Firefly Neuroscience, Inc.; that does not match the registrant identified in this filing.
Key financial results
| Metric | Q1 2015 | Q1 2014 or prior date |
|---|---|---|
| Revenue | $1,476,123 | $1,179,810 |
| Gross profit / margin | $484,255 / 32.8% | $454,278 / 38.5% |
| Operating loss | $(87,310) | $(100,218) |
| Net loss | $(84,831); $(0.01) per share | $(97,519); $(0.01) per share |
| Cash used in operations | $(325,364) | $(78,903) |
| Cash and cash equivalents | $2,122,914 at March 31, 2015 | $2,450,006 at December 31, 2014 |
| Total assets / liabilities | $3,782,926 / $1,774,491 | $4,249,563 / $2,159,168 at December 31, 2014 |
Professional fees were $1,115,096, up 27.4%; software sales were $361,027, up 18.5%. The filing reports no non-current liabilities and no borrowings under its $1 million revolving credit line at quarter-end. No interest or income taxes were paid in the quarter.
Changes versus the prior comparable period
- Revenue increased 25.1%, attributed primarily to federal prime contracts and subcontracts that were not present in Q1 2014.
- Gross profit rose 6.6%, but gross margin fell to 32.8% from 38.5%. Software gross profit was particularly lower because the prior-year period included more high-margin referral fees.
- SG&A excluding commissions declined 3.1% to $432,094; commission expense increased 28.3% to $139,471 alongside higher revenue and commissionable services.
- Net loss narrowed by $12,688. Operating cash use increased to $325,364, with cash also affected by lower deferred revenue and receivables growth.
- Cash declined $327,092 from year-end. Deferred revenue fell $286,885, largely as maintenance-contract revenue was recognized.
Outlook, risks and other items
Management stated that current cash and its operating plan should meet cash requirements for the next 12 months. It reported no material capital-expenditure commitments or off-balance-sheet arrangements. The company had a revolving credit line of up to $1 million, expiring May 31, 2016; an April 21, 2015 amendment is listed as an exhibit, but its terms are not provided in the filing text summarized here.
Customer concentration is significant: five customers generated 76.8% of Q1 2015 revenue, including three federal agencies accounting for 23.5%, 14.9% and 13.9%. Management highlights risks involving federal funding and contracting, competition, technology changes, contract-cost estimates, subcontractor performance, third-party software dependence, and customer economic conditions. It reported no material changes to the risk factors in its 2014 Form 10-K, no legal proceedings, and effective disclosure controls. No specific revenue or earnings guidance was provided.
Important facts for investors to verify
- Confirm the registrant identity: the filing is for Information Analysis Incorporated, not Firefly Neuroscience, Inc.
- Review the April 21, 2015 credit-line amendment and confirm its revised terms and expiration.
- Assess the sustainability of revenue growth given the concentration in a small number of customers and federal contracts.
- Track gross margins, especially software and referral-fee mix, and the rise in operating cash use.
- Compare management’s 12-month liquidity expectation with subsequent cash flow and contract activity.